Valuation: WntResearch AB

Market Cap 127M 13.17M 11.51M 10.62M 9.79M 18.46M 1.27B 18.87M 49.94M 621M 49.47M 48.39M 2.14B P/E 2024 *
-
P/E 2025 -4.79x
Enterprise Value 127M 13.19M 11.53M 10.64M 9.81M 18.48M 1.27B 18.89M 50.01M 622M 49.54M 48.46M 2.14B EV / Sales 2024 *
-
EV / Sales 2025 8,542,354x
Free-Float
1.03%
Yield 2024 *
-
Yield 2025 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%-13.20% - - 13.17M
+0.24%-0.68%+56.19%+57.56% 53.83B
-7.17%-4.39%+42.72%+73.70% 52.1B
+0.28%-1.50%+4.60%+404.96% 23.48B
+0.73%+1.95%-15.68%-14.75% 23.13B
+3.46%+0.79%+34.01%-4.47% 19.36B
-0.91%-2.92%+32.81%-33.26% 17.56B
-5.16%-7.00%+168.44%+291.24% 15.2B
+3.62%-2.42%+29.70%+663.64% 14.83B
+1.13%+0.67%+27.46%+183.92% 14.06B
Average -0.07%-2.95%+42.25%+180.28% 25.95B
Weighted average by Cap. -1.27%-2.58%+41.18%+138.25%

Financials

2024 2025
Net sales - 9.68 1 0.88 0.81 0.75 1.41 96.74 1.44 3.81 47.38 3.77 3.69 163.11
Net income -46.5M -4.82M -4.22M -3.89M -3.59M -6.76M -465M -6.91M -18.29M -228M -18.12M -17.72M -783M -17.23M -1.79M -1.56M -1.44M -1.33M -2.5M -172M -2.56M -6.78M -84.32M -6.71M -6.57M -290M
Net Debt -5.26M -546K -477K -440K -405K -764K -52.53M -781K -2.07M -25.73M -2.05M -2M -88.57M 185K 19.19K 16.77K 15.48K 14.27K 26.89K 1.85M 27.49K 72.76K 905K 72.08K 70.5K 3.12M
Logo WntResearch AB
Opsy Holding AB, formerly WntResearch AB, is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process.
Employees
7